Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1320546
European Journal of Endocrinology, Vol 132, Issue 5, 546-549
Copyright © 1995 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baltisberger, B. L
Right arrow Articles by Bürgi, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Baltisberger, B. L
Right arrow Articles by Bürgi, H.

Decrease of incidence of toxic nodular goitre in a region of Switzerland after full correction of mild iodine deficiency

Benedikt L Baltisberger, Christoph E Minder and Hans Bürgi

Baltisberger BL, Minder CE, Bürgi H. Decrease of incidence of toxic nodular goitre in a region of Switzerland after full correction of mild iodine deficiency. Eur J Endocrinol 1995;132:546–9. ISSN 0804–4643

In 1980 the iodide content of salt was increased in Switzerland from 7.5 to 15 mg/kg. This raised the mean urinary iodine excretion from 90 (indicating mild iodine deficiency) to 150 µg/g creatinine. We examined whether this public health measure was followed by a change of the incidence of hyperthyroidism in a defined catchment area of 109 000 persons. Except for a 27% rise in the first year of the new salt, the total incidence of hyperthyroidism declined steadily to reach 44% of the control level in 1988/89. This was due to a decrease mostly of toxic nodular goitre (minus 73%), less so of Graves' disease (minus 33%). We conclude that correction of mild iodine deficiency has beneficial effects on the incidence of hyperthyroidism, contrary to what is seen initially after correction of severe deficiency.

H Bürgi, Department of Medicine, Bürgerspital, CH-4500 Solothurn, Switzerland




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
I. Bulow Pedersen, P. Laurberg, N. Knudsen, T. Jorgensen, H. Perrild, L. Ovesen, and L. B. Rasmussen
Increase in Incidence of Hyperthyroidism Predominantly Occurs in Young People after Iodine Fortification of Salt in Denmark
J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 3830 - 3834.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
K. Krohn, D. Fuhrer, Y. Bayer, M. Eszlinger, V. Brauer, S. Neumann, and R. Paschke
Molecular Pathogenesis of Euthyroid and Toxic Multinodular Goiter
Endocr. Rev., June 1, 2005; 26(4): 504 - 524.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Krohn and R. Paschke
Progress in Understanding the Etiology of Thyroid Autonomy
J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3336 - 3345.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Aghini-Lombardi, L. Antonangeli, E. Martino, P. Vitti, D. Maccherini, F. Leoli, T. Rago, L. Grasso, R. Valeriano, A. Balestrieri, et al.
The Spectrum of Thyroid Disorders in an Iodine-Deficient Community: The Pescopagano Survey
J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 561 - 566.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Tonacchera, L. Chiovato, A. Pinchera, P. Agretti, E. Fiore, F. Cetani, R. Rocchi, P. Viacava, P. Miccoli, and P. Vitti
Hyperfunctioning Thyroid Nodules in Toxic Multinodular Goiter Share Activating Thyrotropin Receptor Mutations with Solitary Toxic Adenoma
J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 492 - 498.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 European Society of Endocrinology.